This study will demonstrate whether patients with prognostically-significant myocardial abnormalities detected with AI-700 contrast ECHO have a rate of cardiac death or MI that is higher than that of patients with normal AI-700 contrast ECHO.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The primary outcome variable is the time to first occurrence of the composite outcome (death or confirmed non fatal MI).
Timeframe: The time between AI 700 ECHO and outcomes data collection will be ≥12 months with an expected average follow-up period of 24 months